Susy Hota, Susan M. Poutanen
Abstract
Multiple randomized controlled trials show that fecal microbiota transplantation is 44%–96% effective in resolving recurrent C. difficile infection in patients with two or more recurrences.[1][1] This is comparable or superior to conventional treatment with vancomycin taper and pulse, which is
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Multiple randomized controlled trials show that fecal microbiota transplantation is 44%–96% effective in resolving recurrent C. difficile infection in patients with two or more recurrences.[1][1] This is comparable or superior to conventional treatment with vancomycin taper and pulse, which is
Key concepts: Clostridium difficile, Fecal bacteriotherapy, Feces, Transplantation, Medicine, Vancomycin, Clostridium Infections, Randomized controlled trial